In a Landmark Decision by Canada’s Minister of Health, the Honourable Patty Hajdu, Four Terminally Ill Cancer Patients Receiving End-of-Life Care Will Be Legally Allowed to Carry and Consume Psilocybin... read more →
There is a Renaissance in Pharmacology Today, a Sort of Golden Era Inspired By Both the Need to Expedite the Creation of a Vaccine to Treat a Global Pandemic, and... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of July 27th – August 2nd,... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of July 27th – August 2nd,... read more →
As the Psychedelics Industry Gains its Footing as a Better Way to Treat Mental Health, with More Companies Starting up and More Developments in Drug Therapies to Treat Certain Mental... read more →
One of the Outcomes That is Still Not Fully Understood in Using Psilocybin in Psychotherapy is the “Ego-Death” or “Ego-Dissolution” Experience of Those Who Take it During a Controlled Therapy... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of July 20th – 26th, 2020.... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of July 20th – 26th, 2020.... read more →
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FRA: 496) announced on Friday it filed the required Business Acquisition Reports (BAR) in relation to the company's previously announced acquisitions of Artisan Growers,... read more →
Any New Drug Therapy That Can Be Manufactured and Sold in the United States Has to Have the Approval of the U.S. FDA. That’s the Deal. Without That Approval, Which... read more →